Skip to main content

Advertisement

Log in

Left atrial volume index predicts future improvement of B-type natriuretic peptide levels after transcatheter aortic valve replacement

  • Original Paper
  • Published:
The International Journal of Cardiovascular Imaging Aims and scope Submit manuscript

Abstract

In patients with symptomatic severe aortic stenosis (AS), those who experienced readmission due to heart failure after transcatheter aortic valve replacement (TAVR) showed poor prognosis. Furthermore, poor B-type natriuretic peptide (BNP) improvement is associated with increased morbidity and mortality. However, little is known about the clinical parameters related to the change in BNP levels after TAVR procedure. This study population consisted of 127 consecutive patients of symptomatic severe AS with preserved ejection fraction (EF) who underwent transfemoral TAVR (TF-TAVR). Comprehensive transthoracic echocardiography was performed prior to the day of TF-TAVR. BNP was measured serially before and 1 year after TF-TAVR. The median BNP level was significantly decreased from 252.5 pg/ml to 146.8 pg/ml in all 127 patients 1 year after TF-TAVR (P < 0.01). However, the patients could be divided into 2 groups according to decrease (72%) or increase (28%) in plasma BNP level. Multivariate logistic regression analysis revealed that Aortic valve (AV) peak velocity, pre-procedural BNP, and larger left atrial volume index (LAVI) were found to be an independent predictor of increased BNP level 1 year after TAVR (OR 0.55, 95% CI 0.38–0.77; P < 0.01). LAVI were negatively correlated with the change in BNP level before and 1 year after TAVR (r = 0.47, P < 0.01). The ROC analysis demonstrated that 52.9 ml/m2 was the optimal cut-off value of LAVI for decreasing BNP 1 year after TAVR (area under the curve 0.69) with 64% sensitivity and 70% specificity. In addition to AV peak velocity and pre-procedural BNP, LAVI independently predicts future improvement of BNP levels 1 year after TAVR. Our findings indicate an additive predictive value of assessment of LAVI before TAVR procedure for risk stratification.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson JL, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Williams M, Dewey T, Kapadia S, Babaliaros V, Thourani VH, Corso P, Pichard AD, Bavaria JE, Herrmann HC, Akin JJ, Anderson WN, Wang D, Pocock SJ, PARTNER Trial Investigators (2011) Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 364:2187–2198

    Article  CAS  PubMed  Google Scholar 

  2. Mack MJ, Leon MB, Thourani VH, Makkar R, Kodali SK, Russo M, Kapadia SR, Malaisrie SC, Cohen DJ, Pibarot P, Leipsic J, Hahn RT, Blanke P, Williams MR, McCabe JM, Brown DL, Babaliaros V, Goldman S, Szeto WY, Genereux P, Pershad A, Pocock AJ, Alu MC, Webb JG, Smith CR, PARTNER 3 Investigators (2019) Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med 380:1695–1705

    Article  PubMed  Google Scholar 

  3. Makkar RR, Thourani VH, Mack MJ, Kodali SK, Kapadia S, Webb JG, Yoon SH, Trento A, Svensson LG, Herrmann HC, Szeto WY, Miller DC, Satler L, Cohen DJ, Dewey TM, Babaliaros V, Williams MR, Kereiakes DJ, Zajarias A, Greason KL, Whisenant BK, Hodson RW, Brown DL, Fearon WF, Russo MJ, Pibarot P, Hahn RT, Jaber WA, Rogers E, Xu K, Wheeler J, Alu MC, Smith RC, Leon MB, PARTNER 2 Investigators (2020) Five-year outcomes of transcatheter or surgical aortic-valve replacement. N Engl J Med 382:799–809

    Article  PubMed  Google Scholar 

  4. Durand E, Doutriaux M, Bettinger N, Tron C, Fauvel C, Bauer F, Dacher JN, Bouhzam N, Litzler PY, Cribier A, Eltchaninoff H (2017) Incidence, prognostic impact, and predictive factors of readmission for heart failure after transcatheter aortic valve replacement. JACC Cardiovasc Interv 10:2426–2436

    Article  PubMed  Google Scholar 

  5. Jalava MP, Laakso T, Virtaen M, Niemela M, Ahvenvaara T, Tauriainen T, Maaranen P, Husso A, Kinnunen EM, Dahlbacka S, Jaakkola J, Airaksinen J, Anttila V, Rosato S, D’Errigo P, Savontaus M, Laine M, Makikallio T, Valtola A, Raivio P, Eskola M, Biancari F (2020) Transcatheter and surgical aortic valve replacement in patients with recent acute heart failure. Ann Thorac Surg 109:110–117

    Article  PubMed  Google Scholar 

  6. Berger R, Huelsman M, Strecker K, Bojic A, Moser P, Stanek B, Pacher R (2002) B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation 105:2392–2397

    Article  PubMed  Google Scholar 

  7. Volpe M, Rubattu S, Burnett J Jr (2014) Natriuretic peptides in cardiovascular diseases: current use and perspectives. Eur Heart J 35:419–425

    Article  CAS  PubMed  Google Scholar 

  8. Chen S, Redfors B, O’Neill BP, Clavel MA, Pibarot P, Elmariah S, Nazif T, Crowley A, Ben-Yehuda O, Finn MT, Alu MC, Vahl TP, Kodali S, Leon MB, Lindman BR (2019) Low and elevated B-type natriuretic peptide levels are associated with increased mortality in patients with preserved ejection fraction undergoing transcatheter aortic valve replacement: an analysis of the PARTNER II trial and registry. Eur Heart J 41:958–969

    Article  Google Scholar 

  9. Mizutani K, Hara M, Iwata S, Murakami T, Shibata T, Yoshiyama M, Naganuma T, Yamanaka F, Higashimori A, Tada N, Takagi K, Araki M, Ueno H, Tabata M, Shirai S, Watanabe Y, Yamamoto M, Hayashida K (2017) Elevation of B-type natriuretic peptide at discharge is associated with 2-year mortality after transcatheter aortic valve replacement in patients with severe aortic stenosis: insights from a multicenter prospective OCEAN-TAVI (optimized transcatheter valvular intervention-transcatheter aortic valve implantation) registry. J Am Heart Assoc 6:e006112

    Article  PubMed  PubMed Central  Google Scholar 

  10. Ribeiro HB, Urena M, Le Ven F, Nombela-Franco L, Allende R, Clavel MA, Dahou A, Côté M, Laflamme J, Laflamme L, DeLarochellière H, DeLarochellière R, Doyle D, Dumont E, Bergeron S, Pibarot P, Rodés-Cabau J (2014) Long-term prognostic value and serial changes of plasma N-terminal prohormone B-type natriuretic peptide in patients undergoing transcatheter aortic valve implantation. Am J Cardiol 113:851–859

    Article  CAS  PubMed  Google Scholar 

  11. O’Neill BP, Guerrero M, Thourani VH, Kodali S, Heldman A, Williams M, Xu K, Pichard A, Mack M, Babaliaros V, Herrmann HC, Webb J, Douglas PS, Leon MB, O’Neill WW (2015) Prognostic value of serial B-type natriuretic peptide measurement in transcatheter aortic valve replacement (from the PARTNER Trial). Am J Cardiol 115:1265–1272

    Article  CAS  PubMed  Google Scholar 

  12. Koskinas KC, O’Sullivan CJ, Heg D, Praz F, Stortecky S, Pilgrim T, Buellesfeld L, Jüni P, Windecker S, Wenaweser P (2015) Effect of B-type natriuretic peptides on long-term outcomes after transcatheter aortic valve implantation. Am J Cardiol 116:1560–1565

    Article  CAS  PubMed  Google Scholar 

  13. Sato K, Kumar A, Krishnaswamy A, Mick S, Desai MY, Griffin BP, Kapadia SR, Popović ZB (2018) B-type natriuretic peptide is associated with remodeling and exercise capacity after transcatheter aortic valve replacement for aortic stenosis. Clin Cardiol 42:270–276

    Article  PubMed  PubMed Central  Google Scholar 

  14. Baumagarter H, Falk V, Bax JJ, Bonis MD, Hamm C, Holm PJ, Iung B, Lancellotti P, Lansac E, Munoz DR, Rosenhek R, Sjogren J, Mas PT, Vahanian A, Walther T, Wendler O, Windecker S, Zamorano JL (2017) 2017 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J 38:2739–2391

    Article  Google Scholar 

  15. Mitchell C, Rahko P, Blauwet LA, Canaday B, Finstuen JA, Foster MC, Horton K, Ogunyankin KO, Palma RA, Velazquez EJ (2019) Guidelines for performing a comprehensive transthoracic echocardiographic examination in adults: recommendations from the American Society of Echocardiography. J Am Soc Echocardiogr 32:1–64

    Article  PubMed  Google Scholar 

  16. Kanda Y (2013) Investigation of the freely available easy-to-use software “EZR” for medical statistics. Bone Marrow Transpl 48:452–458

    Article  CAS  Google Scholar 

  17. Gerber IL, Stewart RA, Legget ME, West TM, French RL, Sutton TM, Yandle TG, French JK, Richards AM, White HD (2003) Increased plasma natriuretic peptide levels reflect symptom onset in aortic stenosis. Circulation 107:1884–1890

    Article  PubMed  Google Scholar 

  18. Clavel MA, Malouf J, Michelena HI, Suri RM, Jaffe AS, Mahoney DW, Enriquez-Sarano M (2014) B-type natriuretic peptide clinical activation in aortic stenosis: impact on long-term survival. J Am Coll Cardiol 63(19):2016–2025

    Article  CAS  PubMed  Google Scholar 

  19. Lorell BH, Carabello BA (2000) Left ventricular hypertrophy: pathogenesis, detection, and prognosis. Circulation 102:470–479

    Article  CAS  PubMed  Google Scholar 

  20. Daniels LB, Maisel AS (2007) Natriuretic peptides. J Am Coll Cardiol 50:2357–2368

    Article  CAS  PubMed  Google Scholar 

  21. Dalsgaard M, Egstrup K, Wachtell K et al (2008) Left atrial volume in patients with asymptomatic aortic valve stenosis (the Simvastatin and Ezetimibe in Aortic Stenosis study). Am J Cardiol 101:1030–1034

    Article  CAS  PubMed  Google Scholar 

  22. Dalsgaard M, Egstrup K, Wachtell K, Gerdts E, Cramariuc D, Kjaergaard J, Hassager C (2003) Left atrial volume in patients with asymptomatic aortic valve stenosis (the Simvastatin and Ezetimibe in Aortic Stenosis study). J Am Coll Cardiol 42:1206–1207

    Google Scholar 

  23. Mosquera VX, Bouzas-Mosquera A, González-Barbeito M, Bautista-Hernandez V, Muñiz J, Alvarez-García N, Cuenca-Castillo JJ (2017) Indexed left atrial size predicts all-cause and cardiovascular mortality in patients undergoing aortic valve surgery. J Thorac Cardiovasc Surg 153:1275–1284

    Article  PubMed  Google Scholar 

  24. Morimoto J, Hozumi T, Takemoto K, Wada T, Maniwa N, Kashiwagi M, Shimamura K, Shiono Y, Kuroi A, Yamano T, Yamaguchi T, Matsuo Y, Kitabata H, Ino Y, Kubo T, Tanaka A, Nishimura Y, Akasaka T (2019) preoperative left atrial minimum volume as a surrogate marker of postoperative symptoms in senile patients with aortic stenosis who underwent surgical aortic valve replacement. J Cardiol 74:366–371

    Article  PubMed  Google Scholar 

  25. Barbier P, Solomon SB, Schiller NB, Glantz SA (1999) Left atrial relaxation and left ventricular systolic function determine left atrial reservoir function. Circulation 100:427–436

    Article  CAS  PubMed  Google Scholar 

  26. Thomas L, Marwick TH, Popescu BA, Donal E, Badano LP (2019) Left atrial structure and function, and left ventricular diastolic dysfunction: JACC state-of-the-art review. J Am Coll Cardiol 73(15):1961–1977

    Article  PubMed  Google Scholar 

  27. Rusinaru D, Bohbot Y, Kowalski C, Ringle A, Maréchaux S, Tribouilloy C (2017) Left atrial volume and mortality in patients with aortic stenosis. J Am Heart Assoc 6:e006615

    Article  PubMed  PubMed Central  Google Scholar 

  28. Ben-Dor I, Minha S, Barbash IM, Aly O, Dvir D, Deksissa T, Okubagzi O, Torguson R, Lindsay J, Satler LF, Pichard AD, Waksman R (2013) Correlation of brain natriuretic peptide levels in patients with severe aortic stenosis undergoing operative valve replacement or percutaneous transcatheter intervention with clinical, echocardiographic, and hemodynamic factors and prognosis. Am J Cardiol 112:574–579

    Article  CAS  PubMed  Google Scholar 

  29. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA et al (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology. J Am Soc Echocardiogr 18:1440–1463

    Article  PubMed  Google Scholar 

  30. Iwataki M, Takeuchi M, Otani K, Kuwaki H, Haruki N, Yoshitani H, Tamura M, Abe H, Otsuji Y (2012) Measurement of left atrial volume from transthoracic three-dimensional echocardiographic data-sets using the biplane Simpson’s technique. J Am Soc Echocardiogr 25:1319–1326

    Article  PubMed  Google Scholar 

  31. Russo C, Jin Z, Homma S, Rundek T, Elkind MS, Sacco RL, Di Tullio MR (2012) Left atrial minimum volume and reservoir function as correlates of left ventricular diastolic function: impact of left ventricular systolic function. Heart 98:813–820

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Leah Cannon, PhD, from Edanz (https://www.edanz.com/ac) for editing a draft of this manuscript.

Author information

Authors and Affiliations

Authors

Contributions

All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by MO, ATK, RY, YK, TY, YT and TO. The first draft of the manuscript was written by AI and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Asahiro Ito.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the Osaka City University Graduate School of Medicine (Approval Number: 2021-064).

Consent to participate

Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ito, A., Izumiya, Y., Iwata, S. et al. Left atrial volume index predicts future improvement of B-type natriuretic peptide levels after transcatheter aortic valve replacement. Int J Cardiovasc Imaging 38, 1463–1471 (2022). https://doi.org/10.1007/s10554-022-02538-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10554-022-02538-7

Keywords

Navigation